Investing.com - Biondvax Pharma ADR (NASDAQ: BVXV) reported third quarter EPS of $0.003, $0.10 better than the analyst estimate of $-0.100. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Biondvax Pharma ADR's stock price closed at $9.550. It is down -9.05% in the last 3 months and down -44.94% in the last 12 months.
Biondvax Pharma ADR saw positive EPS revisions and negative EPS revisions in the last 90 days. See Biondvax Pharma ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Biondvax Pharma ADR's Financial Health score is " performance".
Check out Biondvax Pharma ADR's recent earnings performance, and Biondvax Pharma ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar